Stay updated on HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Sign up to get notified when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.

Latest updates to the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page
- Check5 days agoChange DetectedNew recruitment status indicates enrollment is closed; new user guidance sections were added, the Intervention/Treatment header formatting was adjusted, and the revision label updated to v3.6.0.SummaryDifference0.5%

- Check12 days agoChange DetectedThe page revision label has been updated to `v3.5.5`, replacing the previous `v3.5.4`. This reflects a minor page build/update.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision label v3.5.4 was added and the previous v3.5.3 was removed. This reflects an internal platform update and does not alter any study data or visible content.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/version change without changing the displayed study information.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

Stay in the know with updates to HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.